Delivery Order SPE2DX22D0010-SPE2D826FAK47
Award Date 10/16/25
Potential Completion Date 10/17/25
Potential Value $36K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $16,827.85 for Vyvanse capsules 70mg on June 16, 2025, with completion expected by June 17, 2025. The contract utilizes firm fixed-price pricing and carries no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its corporate office location...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Vyvanse 30 mg capsules (100-count units) with a ceiling value of $4,698.42. This non-competitive delivery order represents a firm fixed price transaction with a completion date of September 12, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical...
- The U.S. Department of Defense's Medical Supply Chain awarded a $54.8K delivery order to AmerisourceBergen Drug Corp for supply of Vyvanse capsules (30mg) under a firm fixed-price contract. The delivery order, issued on September 11, 2025, with completion targeted for September 12, 2025, was competitively awarded with no set-aside designation. Performance will occur at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, where the company maintains substantial pharmaceutical...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for $13,062.24 to supply Vyvanse capsules 60mg, with an ultimate completion date of October 8, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle. The product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate...
- The Department of Defense's Medical Supply Chain awarded a $26,751.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Vyvanse capsules (50mg) on October 3, 2025, with an ultimate completion date of October 6, 2025. This non-compete, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999.00 and extending through...
- The Defense Logistics Agency's Medical Supply Chain awarded a $17,094.35 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Vyvanse capsules 50mg, with completion targeted for September 15, 2025. This non-set-aside delivery order represents a routine pharmaceutical procurement under AmerisourceBergen's existing contract vehicle and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen is a...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Vyvanse capsules 30mg on June 10, 2025, with a firm fixed price ceiling value of $10,541.69 and ultimate completion date of June 11, 2025. This non-set-aside, competitively awarded contract represents a routine pharmaceutical supply delivery supporting military healthcare operations. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,658.76 to AmerisourceBergen Drug Corp for the supply of Vyvanse capsules (30 mg) on August 20, 2025. This firm fixed-price delivery order, which is expected to be completed by August 21, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was competitively procured with no set-aside designation, leveraging...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on May 20, 2025, for the supply of Vyvanse capsules 60mg, with a ceiling value of $14,818.02. This competitively awarded, firm fixed-price delivery order has an ultimate completion date of May 21, 2025, and represents a child order under AmerisourceBergen's larger pharmaceutical supply vehicle. The product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Vyvanse (lisdexamfetamine dimesylate) 50mg capsules under a firm fixed-price contract valued at $25,229.11, with a completion date of April 22, 2025. This non-competitive delivery order was issued on April 21, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The award represents a single-product pharmaceutical procurement typical of the...